Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/1997
07/29/1997US5652246 Neurokinin receptor antagonists; nervous system disorders
07/29/1997US5652243 Modulating cellular response
07/29/1997US5651957 Administering lantibiotic
07/29/1997CA1339105C Modified proteins
07/24/1997WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE
07/24/1997WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
07/24/1997WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
07/24/1997WO1997025977A1 Pharmaceutical compositions
07/24/1997WO1997007198A3 Dna sequences and secreted proteins encoded thereby
07/24/1997CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives
07/24/1997CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
07/24/1997CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
07/23/1997EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus
07/23/1997EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase
07/23/1997EP0785190A2 Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient
07/23/1997EP0784980A1 Collagen hydrolysis accelerator
07/23/1997EP0630229B1 Pressurized gas packagings using polyoxyethylene glyceryl-obates
07/23/1997EP0581797B1 Novel thiophene-2-carboxylic acid derivatives and process for their production
07/23/1997EP0538332B1 Polycyclic guanine derivatives
07/22/1997US5650444 Bronchodilator agents, antiallergens and antiinflammatory agents
07/22/1997US5650427 Antidepressants
07/22/1997US5650424 Antiagglomerants using imidazolidindiones
07/22/1997US5650414 Pyrazolopyridines or imidazolopyridines
07/17/1997WO1997025331A1 Heterocycle-condensed morphinoid derivatives (ii)
07/17/1997WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
07/17/1997WO1997025047A1 Novel cycloalkyl substituded imidazoles
07/17/1997WO1997025046A1 Novel substituted imidazole compounds
07/17/1997WO1997025045A1 Novel substituted imidazole compounds
07/17/1997WO1997025040A1 Substituted benzopyrans
07/17/1997WO1997024929A1 Human g-protein coupled receptor
07/17/1997CA2242609A1 Heterocycle-condensed morphinoid derivatives (ii)
07/17/1997CA2242327A1 Novel substituted imidazole compounds
07/16/1997EP0783510A1 Human potassium channel 1 and 2 proteins
07/16/1997EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin
07/16/1997EP0783498A1 Substituted aryl piperazines as neurokinin antagonists
07/16/1997EP0783314A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards
07/16/1997EP0783298A1 Spray-dried microparticles as therapeutic vehicles
07/16/1997CN1154705A Organic compound
07/16/1997CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
07/16/1997CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products
07/16/1997CN1154247A Cooling throat oral liquor
07/15/1997US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
07/15/1997US5648373 CoA-IT and PAF inhibitors
07/15/1997US5648341 Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution
07/10/1997WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
07/10/1997WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
07/09/1997EP0782571A1 Compositions and methods for treating mast-cell inflammatory condition
07/09/1997EP0782444A1 Method of inhibiting conditions associated with bradykinin
07/09/1997EP0782441A1 Pharmaceutical control of inflammation
07/09/1997EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents
07/09/1997CN1154117A Synthetic peptide analogs of lung surfactant protein SP-C
07/09/1997CN1153785A Cyclic vasoactive peptide analogs
07/08/1997US5646308 Benzopyran derivatives
07/08/1997US5646144 For treating disorders in which substance p plays a part in development
07/03/1997WO1997023470A1 Biologically active benzothiazolone ethanamines
07/03/1997WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
07/03/1997WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
07/03/1997WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors
07/03/1997WO1997023218A1 A process for regulating vagal tone
07/03/1997CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors
07/03/1997CA2238877A1 Biologically active benzothiazolone ethanamines
07/02/1997EP0781776A2 Water soluble rapamycin esters
07/02/1997EP0781558A2 Pharmaceutical use of heparin cofactor II
07/02/1997EP0781556A1 Use of condensed dihydropyridines for the treatement of chronic inflammatory processes
07/02/1997EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents
07/02/1997EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
07/02/1997EP0781277A1 Neurokinin antagonists
07/02/1997EP0781127A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
07/02/1997EP0730588B1 Isoxazoline compounds as antiinflammatory agents
07/01/1997US5643946 Compounds useful for treating allergic and inflammatory diseases
07/01/1997US5643870 Topical asthma treatment
06/1997
06/26/1997WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022604A1 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
06/26/1997WO1997022586A1 Tri-aryl ethane derivatives as pde iv inhibitors
06/26/1997WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
06/26/1997WO1997022339A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
06/26/1997CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme
06/25/1997EP0706376B1 Anti-angiogenic compositions and methods of use
06/25/1997EP0636141B1 Pyrimidinyl acetamides as elastase inhibitors
06/25/1997CN1152940A Non-splicing variants of gp 350/220
06/25/1997CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor